SCHEMBL6684324

SCHEMBL6684324

Fc1ccc(Nc2nc[nH]c3ncc(-c4ccc(F)cc4)c2-3)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 1/20 0.45
ALDH1A1 P00352 4/20 0.42
CYP1A2 P05177 4/20 0.42
CYP3A4 P08684 4/20 0.42
CLK4 Q9HAZ1 3/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C19 P33261 2/20 0.42
USP2 O75604 1/20 0.42
ALOX15 P16050 1/20 0.42
MAPK1 P28482 1/20 0.42
HIF1A Q16665 1/20 0.42
MAPK10 P53779 2/20 0.41
MAPK14 Q16539 2/20 0.41
AURKA O14965 1/20 0.39
TSHR P16473 2/20 0.39
CDK1 P06493 1/20 0.38
QPCT Q16769 1/20 0.37
FGFR1 P11362 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6270213 0.93 FGFR1 (0.44) MKNK1ALDH1A1CYP1A2CYP3A4CLK4
SCHEMBL6677800 0.83 MAPT (0.46) ALDH1A1CYP1A2CYP3A4CLK4CYP2D6
SCHEMBL6683647 0.80 PDE5A (0.41) MKNK1CLK4MAPTHPGDTTBK1
SCHEMBL6876454 0.75 PTK2 (0.40) MAPK10AURKACDK1FGFR1MAPT
SCHEMBL6876431 0.70 POLB (0.44) ALDH1A1CYP1A2CYP3A4CLK4CYP2D6
SCHEMBL17364048 0.63 ADORA1 (0.48) ALDH1A1CYP1A2CYP3A4CLK4CYP2D6
SCHEMBL4922514 0.63 MKNK1 (0.61) MKNK1MAPK1AURKATDP1GRM4
SCHEMBL4922517 0.62 MKNK1 (1.00) MKNK1MAPK1TSHRMAPTHPGD
SCHEMBL2041513 0.62 DHODH (0.56) MKNK1MAPK1MAPK10AURKAMAPT
SCHEMBL7211879 0.61 PTGS2 (0.60) MAPK1MAPK10MAPK14AURKAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832092-B1 ORALLY ACTIVE ADENOSINE KINASE INHIBITORS METABASIS THERAPEUTICS INC (US) 2004-11-17 EP disclosed
EP-0832091-B1 C-4' MODIFIED ADENOSINE KINASE INHIBITORS GENSIA SICOR INC (US) 2004-01-14 EP disclosed
EP-0832092-A1 ORALLY ACTIVE ADENOSINE KINASE INHIBITORS GENSIA, INC. (US) 1998-04-01 EP disclosed
WO-1996040706-A1 ORALLY ACTIVE ADENOSINE KINASE INHIBITORS GENSIA-SICOR (US) 1996-12-19 WO disclosed